Table 2
Mean sensitivity in the area of the original lesion
| Patient no | Type of CNVM lesion | 0 months | 12 months | p Value | Net change in mean sensitivity 0–12 months (dB) | VA | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| dB (SD) | dB (SD) | 0 months | 12 months | ||||||||
| 2 | Cl regression | 16 (4.6) | 5.3 (4.6) | −10.7 | 20/160 | 20/400 | |||||
| 6 | Cl regression | 7.8 (6.8) | 12.7 (8.3) | 4.9 | 20/126 | 20/640 | |||||
| 13 | Cl regression | 3.6 (5) | 5.6 (7.1) | 2 | 20/160 | 20/320 | |||||
| 15 | Cl regression | 6.3 (6.6) | 4.2 (5.4) | −2.2 | 20/200 | 20/250 | |||||
| 17 | Cl regression | 9.5 (7.8) | 14.5 (12) | 5 | 20/40 | 20/80 | |||||
| 18 | Cl regression | 14.6 (3.2) | 10.1 (5.8) | −4.5 | 20/80 | 20/126 | |||||
| 19 | Cl regression | 14.2 (6.5) | 9.2 (9.1) | −5 | 20/50 | 20/64 | |||||
| 20 | Cl regression | 7 (7.8) | 10.4 (7.3) | 3.4 | 20/80 | 20/100 | |||||
| Mean (SD) | 9.9 (6.0) | 9 (7.4) | 0.67 | ||||||||
| 8 | Occ regression | 10.8 (11.2) | 8.3 (8.5) | −2.5 | 20/500 | 20/250 | |||||
| 12 | Occ regression | 10 (6) | 6 (6.2) | −4 | 20/80 | 20/50 | |||||
| 16 | Occ regression | 13.4 (4.8) | 17.3 (6.4) | 3.9 | 20/200 | 20/200 | |||||
| Mean (SD) | 11.4 (7.3) | 10.5 | 0.75 | ||||||||
| All patients with regression of CNVM | 10.3 (6.4) | 9.4 (7.3) | 0.58 | −0.9 | |||||||
| 1 | Cl progression | 4.9 (5.4) | 0 | −4.9 | 20/160 | 20/400 | |||||
| 3 | Cl progression | 17 (2.2) | 3.5 | −13.5 | 20/126 | 20/400 | |||||
| 14 | Cl progression | 2.3 (3.1) | 0 | −2.3 | 20/50 | 20/640 | |||||
| Mean (SD) | 8.1 (3.6) | 1.2 (0.9) | 0.18 | ||||||||
| 11 | Occ progression | 9.8 (6.6) | 0 (0) | −9.8 | 20/80 | 20/500 | |||||
| 7 | Haem, progression | 15.8 (5.8) | 1.5 (2.8) | −14.3 | 20/40 | 20/126 | |||||
| All patients with progression of CNVM | 9.9 (4.6) | 1.0 (1.1) | 0.019 | −8.9 | |||||||
| p=0.011 | |||||||||||
| Fellow eyes, no late AMD (n = 8) | 22.9 (0.8) | 20/32 | |||||||||
| Fellow eyes, late AMD (n = 9) | 5.6 (2.9) | p=0.14, p<0.001 | 20/400 | ||||||||
